These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8986559

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cefetamet pivoxil treatment causes loss of carnitine reserves that can be prevented by exogenous carnitine administration.
    Pap M, Kopcsányi G, Bieber LL, Gage DA, Melegh B.
    J Nutr Biochem; 1999 Nov; 10(11):670-3. PubMed ID: 15539265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
    Hayton WL, Kneer J, Blouin RA, Stoeckel K.
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.
    Blouin RA, Kneer J, Stoeckel K.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):291-6. PubMed ID: 2729925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Antimicrobial activities of cefetamet against clinical isolates from urinary tract infection].
    Ishii Y, Suzuki Y, Ishihara R, Nakazawa A, Deguchi K.
    Jpn J Antibiot; 1996 Dec; 49(12):1073-84. PubMed ID: 9032594
    [Abstract] [Full Text] [Related]

  • 14. Cefetamet pivoxil in the treatment of pharyngotonsillitis due to group A beta-hemolytic streptococci: preliminary report.
    Gervaix A, Brighi L, Halpérin DS, Suter S.
    J Chemother; 1995 May; 7 Suppl 1():21-4. PubMed ID: 8618109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients].
    Fujii R, Chiba S, Numazaki K, Mori T, Terashima I, Meguro H, Mori A, Toyonaga Y, Sunakawa K, Satoh Y.
    Jpn J Antibiot; 1993 Oct; 46(10):926-37. PubMed ID: 8254895
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children.
    Hayton WL, Walstad RA, Thurmann-Nielsen E, Kufaas T, Kneer J, Ambros RJ, Rugstad HE, Monn E, Bodd E, Stoeckel K.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):720-5. PubMed ID: 2069377
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers.
    Tam YK, Kneer J, Dubach UC, Stoeckel K.
    Antimicrob Agents Chemother; 1989 Jun; 33(6):957-9. PubMed ID: 2764545
    [Abstract] [Full Text] [Related]

  • 19. Cefetamet pivoxil a new oral cephalosporin: clinical evaluation.
    Kissling M, Germano G, Fernex M.
    Chemotherapy; 1988 Jun; 34(6):519-29. PubMed ID: 3243094
    [Abstract] [Full Text] [Related]

  • 20. Cefetamet pivoxil in otitis media.
    Quevedo A, Sossouhounto R, Kissling M.
    ORL J Otorhinolaryngol Relat Spec; 1993 Jun; 55(2):93-6. PubMed ID: 8446394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.